Literature DB >> 23193033

No evidence that common genetic risk variation is shared between schizophrenia and autism.

Jacob A S Vorstman1, Richard J L Anney, Eske M Derks, Louise Gallagher, Michael Gill, Maretha V de Jonge, Herman van Engeland, René S Kahn, Roel A Ophoff.   

Abstract

The similarity between aspects of the clinical presentation of schizophrenia and autism spectrum disorders (ASD) suggests that elements of the biological etiology may also be shared between these two disorders. Recently, an increasing number of rare, mostly structural genetic variants are reported to increase the risk of both schizophrenia and ASD. We hypothesized that given this evidence for a shared genetic background based on rare genetic variants, common risk alleles may also be shared between ASD and schizophrenia. To test this hypothesis, the polygenic score, which summarizes the collective effect of a large number of common risk alleles, was used. We examined whether the polygenic score derived from a schizophrenia case-control dataset, previously reported by Purcell et al., was able to differentiate ASD cases from controls. The results demonstrate that the schizophrenia-derived polygenic score is not different between ASD cases and controls, indicating that there is no important sharing of common risk alleles between the two neuropsychiatric disorders. Possibly, common risk alleles are less important in ASD in comparison to their more prominent role in schizophrenia and bipolar disorders. These findings provide important novel insights into shared and distinct elements of the genetic architecture of autism and schizophrenia.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23193033     DOI: 10.1002/ajmg.b.32121

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  7 in total

Review 1.  Using genetic findings in autism for the development of new pharmaceutical compounds.

Authors:  Jacob A S Vorstman; Will Spooren; Antonio M Persico; David A Collier; Stefan Aigner; Ravi Jagasia; Jeffrey C Glennon; Jan K Buitelaar
Journal:  Psychopharmacology (Berl)       Date:  2013-11-30       Impact factor: 4.530

2.  Common polygenic variation and risk for childhood-onset schizophrenia.

Authors:  K Ahn; S S An; Y Y Shugart; J L Rapoport
Journal:  Mol Psychiatry       Date:  2014-12-16       Impact factor: 15.992

Review 3.  Autism spectrum disorder and schizophrenia: An updated conceptual review.

Authors:  Amandeep Jutla; Jennifer Foss-Feig; Jeremy Veenstra-VanderWeele
Journal:  Autism Res       Date:  2021-12-29       Impact factor: 5.216

4.  Polygenic risk scores for smoking: predictors for alcohol and cannabis use?

Authors:  Jacqueline M Vink; Jouke Jan Hottenga; Eco J C de Geus; Gonneke Willemsen; Michael C Neale; Helena Furberg; Dorret I Boomsma
Journal:  Addiction       Date:  2014-03-18       Impact factor: 6.526

5.  Polygenic risk for five psychiatric disorders and cross-disorder and disorder-specific neural connectivity in two independent populations.

Authors:  Tianqi Wang; Xiaolong Zhang; Ang Li; Meifang Zhu; Shu Liu; Wen Qin; Jin Li; Chunshui Yu; Tianzi Jiang; Bing Liu
Journal:  Neuroimage Clin       Date:  2017-02-13       Impact factor: 4.881

Review 6.  Essential genetic findings in neurodevelopmental disorders.

Authors:  Ana R Cardoso; Mónica Lopes-Marques; Raquel M Silva; Catarina Serrano; António Amorim; Maria J Prata; Luísa Azevedo
Journal:  Hum Genomics       Date:  2019-07-09       Impact factor: 4.639

Review 7.  Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice.

Authors:  Joanne L Doherty; Michael J Owen
Journal:  Genome Med       Date:  2014-04-28       Impact factor: 11.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.